U.S. markets closed

Amgen Inc. (AMGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
251.38+1.07 (+0.43%)
At close: 4:00PM EDT

Amgen Inc.

One Amgen Center Drive
Thousand Oaks, CA 91320-1799
United States
805 447 1000
http://www.amgen.com

Sector(s)Healthcare
IndustryDrug Manufacturers—General
Full Time Employees24,300

Key Executives

NameTitlePayExercisedYear Born
Mr. Robert A. BradwayChairman, CEO & Pres5.73M20.29M1963
Mr. Peter H. GriffithExec. VP & CFO2.57MN/A1959
Mr. Esteban SantosExec. VP of Operations2.59MN/A1968
Dr. David M. Reese M.D.Exec. VP of R&D2.71M225.29k1963
Mr. Murdo GordonExec. VP of Global Commercial Operations2.88MN/A1967
Ms. Linda H. LouieVP of Fin. & Chief Accounting OfficerN/AN/AN/A
Mr. Mike ZahigianSr. VP & Chief Information OfficerN/AN/AN/A
Mr. Arvind SoodVP of Investor RelationsN/AN/AN/A
Mr. Jonathan P. GrahamExec. VP, Gen. Counsel & Sec.N/AN/A1961
Ms. Nancy A. GrygielSr. VP of Worldwide Compliance & Bus. Ethics and Chief Compliance OfficerN/AN/A1968
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; and Datos Health. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

Corporate Governance

Amgen Inc.’s ISS Governance QualityScore as of April 30, 2021 is 2. The pillar scores are Audit: 1; Board: 9; Shareholder Rights: 1; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.